Connect with us

Hi, what are you looking for?

Saturday, Dec 4, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Jushi lowers annual revenue guidance

Delays to store openings and ‘unforeseen’ regulatory issues have caused the firm to rein in its earnings projections for the year

Jushy lowers annual revenue guidance
Image via Jushy

While multistate operator Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) drove up revenue in its third fiscal quarter, it fell just short of analysts’ estimates and is lowering its projections for the year.

On Wednesday, the U.S. firm released its earnings for the three months ended Sept. 30, with revenue rising 13 per cent to US$54 million from US$47.7 million last quarter.

Earnings estimates for Jushi ranged from US$54.3 million on the low end to US$57.7 million on the high end, according to Yahoo Finance.

Gross profit rose over 11 per cent in the period to US$24.5 million.

General, administrative and selling expenses fell slightly to US$24.3 million. But excluding one-time severance costs last quarter, operating costs rose US$1.3 million, driven primarily by staff hirings to support new store openings, as well as an increase in activity at Jushi’s cultivation and manufacturing facilities.

Net income spiked to US$38.2 million from US$4.8 million last quarter, which the company primarily attributed to a US$55-million fair value gain on derivative warrants.

Read more: Passing of ‘historic’ MORE Act moot unless Georgia runoff swings blue

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose almost 36 per cent to US$6.4 million.

In a statement, CEO Jim Cacioppo reduced his firm’s 2021 revenue guidance to US$205–215 million from US$220–230 million previously, and similarly downgraded adjusted EBITDA guidance to US$21–25 million from US$110–130 million.

“The reduction in revenue and adjusted EBITDA guidance was driven by (1) delays in new store openings, due to unforeseen regulatory approval timing-related delays; (2) slower than expected ramp-up of wholesale activity in Massachusetts due to the lack of wholesale operating infrastructure by the previous operator; (3) ongoing regulatory complexities that have impeded our ability to introduce our full suite of flower products in Virginia; and (4) a delay in signing and closing of acquisitions in Nevada,” he said in a statement.

“We also incurred greater than expected corporate overhead as we have ramped up hiring to support our continued growth.”

During the quarter, Jushi cut a deal to acquire an Apothecarium store in Las Vegas, launched flower sales in Virginia, acquired retail and cultivation in Massachusetts, as well as opened two new stores in Pennsylvania.

It also won a US$16.4 million award following a legal dispute that a medical cannabis licensee in Florida improperly ended a franchise agreement in 2018.

Company stock inched down almost 2 per cent Wednesday to C$5.75 on the Canadian Securities Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe